CPIG
TMCI icon

Chicago Partners Investment Group’s Treace Medical Concepts TMCI Stock Holding History

Chicago Partners Investment Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.2K Sell
24,254
-1,760
-7% -$4.84K ﹤0.01% 1480
2026
Q1 		$48.6K Buy
26,014
+6,606
+34% +$13.2K ﹤0.01% 1423
2025
Q4 		$50.1K Sell
19,408
-377
-2% -$1.64K ﹤0.01% 1280
2025
Q3 		$135K Sell
19,785
-734
-4% -$4.79K ﹤0.01% 1177
2025
Q2 		$125K Sell
20,519
-238
-1% -$1.55K ﹤0.01% 1060
2025
Q1 		$149K Buy
20,757
+1,344
+7% +$12.1K 0.01% 884
2024
Q4 		$147K Buy
19,413
+57
+0.3% +$381 ﹤0.01% 826
2024
Q3 		$98.3K Hold
19,356
– – ﹤0.01% 783
2024
Q2 		$144K Buy
+19,356
New +$156K 0.01% 724

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Chicago Partners Investment Group's TMCI Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Treace Medical Concepts (TMCI) stake by 6.8% in Q2 2026, selling an estimated $4.84K and leaving 24,254 shares worth $98.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Chicago Partners Investment Group first reported a position in TMCI in Q2 2024 and has held it in 9 quarters since. The position peaked at $149K in Q1 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Chicago Partners Investment Group held 24,254 shares of Treace Medical Concepts worth $98.2K as of Q2 2026.
  • Chicago Partners Investment Group sold 1,760 Treace Medical Concepts shares in Q2 2026, an estimated $4.84K.
  • Treace Medical Concepts made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1480 holding.
  • Chicago Partners Investment Group first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 9 quarters since.
  • Chicago Partners Investment Group's Treace Medical Concepts position peaked at $149K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.